Stock BMMJ BODY AND MIND INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Body and Mind Inc. Share Price Other OTC

Equities

BMMJ

US09689V1008

Pharmaceuticals

Financials

Sales 2022 31.64M 2.5B Sales 2023 22.82M 1.81B Capitalization 11.88M 940M
Net income 2022 -28M -2.22B Net income 2023 -20M -1.58B EV / Sales 2022 0.73 x
Net Debt 2022 11.67M 924M Net Debt 2023 18.38M 1.45B EV / Sales 2023 1.33 x
P/E ratio 2022
-0.39 x
P/E ratio 2023
-0.52 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 86.53%
More Fundamentals * Assessed data

Chart Body and Mind Inc.

Dynamic Chart

Latest news about Body and Mind Inc.

Body and Mind Fiscal Q3 Loss Widens, Revenue Grows MT
Body and Mind Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024 CI
Body and Mind Narrows Fiscal Q2 Loss MT
Body and Mind Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 CI
Body and Mind Inc. announced that it has received CAD 0.240246 million in funding CI
Vegas Brazil LLC entered into a purchase agreement to acquire Nevada Medical Group, LLC from Body and Mind Inc. for $2 million. CI
Body and Mind Inc. Receives State Approval for New Jersey Dispensary CI
Body and Mind Reports Completion of Markham Illinois Dispensary Transaction MT
Body and Mind Announces Closing of Markham Illinois Dispensary Transaction CI
Body and Mind Swings to Profit in Fiscal Q1, Revenue Drops MT
Body and Mind Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023 CI
Body and Mind Inc. completed the acquisition of Airport Collective, Inc. from Green Light District Holdings, Inc. CI
Body and Mind Inc. Reports Earnings Results for the Full Year Ended July 31, 2023 CI
Body and Mind's Fiscal Q3 Loss Widens, Sales Fall MT
Body and Mind Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023 CI
More news

Press releases Body and Mind Inc.

Body and Mind Announces Q3 2024 Financial Results NE
Body and Mind Announces Q2 2024 Financial Results NE
Body and Mind Provides Update on Optimization Initiatives NE
Body and Mind Awarded State Approval for New Jersey Dispensary NE
Body and Mind Announces Closing of Markham Illinois Dispensary Transaction NE
More press releases

Managers and Directors - Body and Mind Inc.

Managers TitleAgeSince
Michael Mills CEO
 Chief Executive Officer 55 11/06/18
Dong Shim DFI
 Director of Finance/CFO 40 14/12/16
Stephen Trip Hoffman COO
 Chief Operating Officer 59 14/11/18
Members of the board TitleAgeSince
Joshua Rosen BRD
 Director/Board Member 51 31/01/23
Brent Reuter BRD
 Director/Board Member 56 15/10/19
Michael Mills CEO
 Chief Executive Officer 55 11/06/18
More insiders

Company Profile

Body and Mind Inc. is a Canada-based operations-focused cannabis company with active retail operations in Arkansas, Illinois and California, pending retail operations in New Jersey, and craft cultivation operations in Arkansas. The Company's segments include Wholesale, Retail and All others. The Company's products include flowers, pre rolls and hemp blunts, concentrates, carts and vapes, and edibles. Its featured products include Krispy Bites, Pretzel Bites and Chocolate Bites. It manages and operates a BaM Body and Mind branded dispensary. It owns and operates The Reef by Body and Mind retail dispensary in the limited license jurisdiction of Seaside, California. The Company's subsidiary is DEP Nevada Inc.
Sector
Pharmaceuticals
Calendar
14/11/2024 - Q4 2024 Earnings Release (Projected)
More about the company

Sector Alternative Medicine

1st Jan change Capi.
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+29.76% 5.69B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-32.34% 3.53B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
-2.23% 3.06B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-25.26% 2.62B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-10.88% 2.29B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+40.09% 1.86B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+40.90% 1.43B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-15.16% 1.41B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK Stock PT Industri Jamu dan Farmasi Sido Muncul Tbk
+42.86% 1.4B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. BMMJ Stock
  4. BMMJ Stock